Racial differences in CT phenotypes in COPD

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 10, Issue 1, 2013, Pages 20-27

  Hansel, Nadia N ^a   Washko, George R ^b   Foreman, Marilyn G ^c   Han, Meilan K ^d   Hoffman, Eric A ^e   Demeo, Dawn L ^b   Barr, R Graham ^f   Van Beek, Edwin J R ^g   Kazerooni, Ella A ^d   Wise, Robert A ^a   Brown, Robert H ^a   Black Shinn, Jennifer ^h   Hokanson, John E ^h   Hanania, Nicola A ⁱ   Make, Barry ^j   Silverman, Edwin K ^b   Crapo, James D ^j   Dransfield, Mark T ^k  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MOREHOUSE SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f Columbia University ^*  (United States)

^g UNIVERSITY OF EDINBURGH   (United Kingdom)

^h UNIVERSITY OF COLORADO   (United States)

ⁱ BAYLOR COLLEGE OF MEDICINE   (United States)

^j DEPARTMENT OF MEDICINE   (United States)

^k UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

more..

Author keywords

Air trapping; Airway wall thickness; Chronic obstructive pulmonary disease; Emphysema; Quantitative CT; Race

Indexed keywords

AGED; AIRWAY REMODELING; ARTICLE; ASTHMA; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; FUNCTIONAL STATUS; HUMAN; LUNG EMPHYSEMA; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RACE DIFFERENCE; RESPIRATORY TRACT PARAMETERS; SMOKING;

AFRICAN AMERICANS; AGED; AIRWAY REMODELING; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84874084004     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2012.727921     Document Type: Article

References (39)

1. Coultas DB, Mapel D, Gagnon R, Lydick E. The health impact of undiagnosed airflow obstruction in a national sample of United States adults. Am J Respir Crit Care Med 2001; 164(3):372-377.
2. Kirkpatrick P, Dransfield MT. Racial and sex differences in chronic obstructive pulmonary disease susceptibility, diagnosis, and treatment. Curr Opin Pulm Med 2009; 15(2):100-104.
3. Wise RA. Changing smoking patterns and mortality from chronic obstructive pulmonary disease. Prev Med 1997; 26(4):418-421.
4. Gillum RF. Chronic obstructive pulmonary disease in blacks and whites: pulmonary function norms and risk factors. J Natl Med Assoc 1991; 83(5):393-401.
5. Berg JZ, Mason J, Boettcher AJ, Hatsukami DK, Murphy SE. Nicotine metabolism in African Americans and European Americans: variation in glucuronidation by ethnicity and UGT2B10 haplotype. J Pharmacol Exp Ther 2010; 332(1):202-209.
6. Chatila WM, Hoffman EA, Gaughan J, Robinswood GB, Criner GJ. Advanced emphysema in African-American and white patients: do differences exist? Chest 2006; 130(1):108-118.
7. Dransfield MT, Bailey WC. COPD: Racial disparities in susceptibility, treatment, and outcomes. Clin Chest Med 2006; 27(3):463-471, vii.
8. Dransfield MT, Bailey WC. Studying COPD in African-Americans: Better late than never. COPD 2008; 5(1):1-3.
9. Han MK, Bartholmai B, Liu LX, et al. Clinical significance of radiologic characterizations in COPD. COPD 2009; 6(6):459-467.
10. Regan EA, Hokanson JE, Murphy JR, et al. Genetic epidemiology of COPD (COPDGene) study design. COPD 2010; 7(1):32-43.
11. American Thoracic Society. Standardization of Spirometry, 1994 Update. Am J Respir Crit Care Med 1995; 152(3):1107-1136.
12. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159(1):179-187.
13. ATS statement. Guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166(1):111-117.
14. Barr JT, Schumacher GE, Freeman S, LeMoine M, Bakst AW, Jones PW. American translation, modification, and validation of the St. George's Respiratory Questionnaire. Clin Ther 2000; 22(9):1121-1145.
15. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350(10):1005-1012.
16. Hoffman EA, Simon BA, McLennan G. State of the Art. A structural and functional assessment of the lung via multidetector-row computed tomography: phenotyping chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006; 3(6):519-532.
17. Han MK, Kazerooni EA, Lynch DA, et al. Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology 2011; 261(1):274-282.
18. Busacker A, Newell JD, Jr., Keefe T, et al. A multivariate analysis of risk factors for the air-trapping asthmatic phenotype as measured by quantitative CT analysis. Chest 2009; 135(1):48-56.
19. Jain N, Covar RA, Gleason MC, Newell JD, Jr., Gelfand EW, Spahn JD. Quantitative computed tomography detects peripheral airway disease in asthmatic children. Pediatr Pulmonol 2005; 40(3):211-218.
20. Kim WJ, Silverman EK, Hoffman E, et al. CT metrics of airway disease and emphysema in severe COPD. Chest 2009; 136(2):396-404.
21. Hersh CP, Washko GR, Jacobson FL, et al. Interobserver variability in the determination of upper lobe-predominant emphysema. Chest 2007; 131(2):424-431.
22. Han MK, Curran-Everett D, Dransfield MT, et al. Racial differences in quality of life in patients with COPD. Chest 2011; 140(5):1169-1176.
23. Rambod M, Porszasz J, Make BJ, Crapo JD, Casaburi R. Six minute walk distance predictors, including computed tomography measures, in the COPDGene(R) Cohort. Chest 2012; 141(4):867-875.
24. Flaherty KR, Kazerooni EA, Curtis JL, et al. Short-term and long-term outcomes after bilateral lung volume reduction surgery : Prediction by quantitative CT. Chest 2001; 119(5):1337-1346.
25. Chae EJ, Seo JB, Song JW, et al. Slope of emphysema index: an objective descriptor of regional heterogeneity of emphysema and an independent determinant of pulmonary function. AJR Am J Roentgenol 2010; 194(3):W248-W255.
26. Gietema HA, Zanen P, Schilham A, et al. Distribution of emphysema in heavy smokers: impact on pulmonary function. Respir Med 2010; 104(1):76-82.
27. Mohamed Hoesein FA, van Rikxoort E, van Ginneken B, et al. CT-quantified emphysema distribution is associated with lung function decline. Eur Respir J 2012, in press.
28. Tanabe N, Muro S, Tanaka S, et al. Emphysema distribution and annual changes in pulmonary function in male patients with chronic obstructive pulmonary disease. Respir Res 2012; 13(1):31.
29. de Serres FJ. Worldwide racial and ethnic distribution of alpha1-Antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys. Chest 2002; 122(5):1818-1829.
30. Mair G, Maclay J, Miller JJ, et al. Airway dimensions in COPD: Relationships with clinical variables. Respir Med 2010; 104(11):1683-1690.
31. Hogg JC, Chu F, Utokaparch S, et al. The nature of smallairway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350(26):2645-2653.
32. Matsuoka S, Yamashiro T, Washko GR, Kurihara Y, Nakajima Y, Hatabu H. Quantitative CT assessment of chronic obstructive pulmonary disease. Radiographics 2010; 30(1):55-66.
33. Sarrazin MV, Cannon KT, Rosenthal GE, Kaldjian LC. Racial differences in mortality among veterans hospitalized for exacerbation of chronic obstructive pulmonary disease. J Natl Med Assoc 2009; 101(7):656-662.
34. Shaya FT, Maneval MS, Gbarayor CM, et al. Burden of COPD, asthma, and concomitant COPD and asthma among adults: racial disparities in a medicaid population. Chest 2009; 136(2):405-411.
35. Mohamed Hoesein FA, de HB, Zanen P, et al. CT-quantified emphysema in male heavy smokers: association with lung function decline. Thorax 2011; 66(9):782-787.
36. Haruna A, Muro S, Nakano Y, et al. CT scan findings of emphysema predict mortality in COPD. Chest 2010; 138(3):635-640.
37. Martinez FJ, Foster G, Curtis JL, et al. Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 2006; 173(12):1326-1334.
38. Dawkins PA, Dowson LJ, Guest PJ, Stockley RA. Predictors of mortality in alpha1-Antitrypsin deficiency. Thorax 2003; 58(12):1020-1026.
39. Kuempel ED, Wheeler MW, Smith RJ, Vallyathan V, Green FH. Contributions of dust exposure and cigarette smoking to emphysema severity in coal miners in the United States. Am J Respir Crit Care Med 2009; 180(3):257-264.